Verici Dx is a health care company that conducts tests, tracks the overall records, and journey of kidney transplant patients.
Verici Dx has raised $7.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2025.
Verici Dx's investors include Harwood Capital Management, Sara Barrington, Julian Baines, Sir Ian Carruthers, David Anderson.
Verici Dx is headquartered in New York, United States.
Verici Dx is a health care company that conducts tests, tracks the overall records, and journey of kidney transplant patients.
Verici Dx is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Verici Dx — Funding & Investors." VCBacked, July 21, 2025, https://www.vcbacked.co/company/verici-dx. Accessed September 30, 2026.
VCBacked. (2025). Verici Dx — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/verici-dx
{{cite web |title=Verici Dx — Funding & Investors |url=https://www.vcbacked.co/company/verici-dx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated